Potent antitumor activity of a urokinase-activated engineered anthrax toxin

AUTOR(ES)

Liu, Shihui

FONTE

The National Academy of Sciences

RESUMO

The acquisition of cell-surface urokinase plasminogen activator activity is a hallmark of malignancy. We generated an engineered anthrax toxin that is activated by cell-surface urokinase in vivo and displays limited toxicity to normal tissue but broad and potent tumoricidal activity. Native anthrax toxin protective antigen, when administered with a chimeric anthrax toxin lethal factor, Pseudomonas exotoxin fusion protein, was extremely toxic to mice, causing rapid and fatal organ damage. Replacing the furin activation sequence in anthrax toxin protective antigen with an artificial peptide sequence efficiently activated by urokinase greatly attenuated toxicity to mice. In addition, the mutation conferred cell-surface urokinase-dependent toxin activation in vivo, as determined by using a panel of plasminogen, plasminogen activator, plasminogen activator receptor, and plasminogen activator inhibitor-deficient mice. Surprisingly, toxin activation critically depended on both urokinase plasminogen activator receptor and plasminogen in vivo, showing that both proteins are essential cofactors for the generation of cell-surface urokinase. The engineered toxin displayed potent tumor cell cytotoxicity to a spectrum of transplanted tumors of diverse origin and could eradicate established solid tumors. This tumoricidal activity depended strictly on tumor cell-surface plasminogen activation. The data show that a simple change of protease activation specificity converts anthrax toxin from a highly lethal to a potent tumoricidal agent.

Documentos Relacionados

• Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis
• Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors
• Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers.
• Proteasome Activity Is Required for Anthrax Lethal Toxin To Kill Macrophages
• Esperamicins, a class of potent antitumor antibiotics: mechanism of action.